Phase 1/2 survival data from GOBLET pancreatic cancer cohort demonstrates improvements over historical control trials
Award and grant funding from Pancreatic Cancer Action Network (PanCAN) provides financial boost and will enable further evaluation of pelareorep in pancreatic cancer
Read more at newswire.ca